- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about MESO
Recent news which mentions MESO
From Benzinga
William Blair Initiates Mesoblast Soon After Its Lead Product Goes Under FDA Review In Pediatric Indication
March 09, 2023
Tickers
MESO
From Benzinga
Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 08, 2023
From Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 08, 2023
From Benzinga
Mesoblast, Arlo Technologies, CPI Card Group And Other Big Stocks Moving Higher On Wednesday
March 08, 2023
From Benzinga
Mesoblast's Lead Drug Candidate Goes Under FDA Priority Review For Bone Marrow Transplant Complications In Kids
March 08, 2023
Tickers
MESO
From Benzinga
From Benzinga
Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket
March 08, 2023
From Benzinga
From InvestorPlace
Dow Dips 300 Points; Snap Shares Plunge
February 01, 2023
From Benzinga
Silicon Laboratories, Credit Acceptance, Stryker And Other Big Stocks Moving Higher On Wednesday
February 01, 2023
From Benzinga
US Stocks Open Lower; Dow Drops 125 Points
February 01, 2023
From Benzinga
Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session
November 30, 2022
From Benzinga
Workday, XPeng, Titan Machinery And Some Other Big Stocks Moving Higher On Wednesday
November 30, 2022
From Benzinga
Mesoblast Lead Product Shows Durable Long-Term Survival At Four Years In Kids With Graft Versus Host Disease
November 23, 2022
Tickers
MESO
From Benzinga
A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field
October 13, 2022
From Benzinga
From Benzinga
Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session
October 03, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022
September 06, 2022
From Benzinga
From InvestorPlace
Mesoblast Limited (MESO) Q1 2022 Earnings Call Transcript
March 28, 2022
Tickers
MESO
From Motley Fool
87 Biggest Movers From Yesterday
March 10, 2022
From Benzinga
50 Stocks Moving In Wednesday's Mid-Day Session
March 09, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 16, 2021
From Benzinga
FDA's Office Agrees On 12-Month Reduction In Pain As Primary Endpoint For Mesoblast's Back Pain Study
December 16, 2021
Tickers
MESO
From Benzinga
The Daily Biotech Pulse: Calliditas Snags FDA Nod, Novartis to Buy Back $15B In Shares, Valneva Touts Vaccine Data, Immix, Bionomics Debut On Wall Street
December 16, 2021
From Benzinga
46 Biggest Movers From Yesterday
December 16, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.